Literature DB >> 2532506

Inhibition of the purified human red-cell Ca2+ pump by a monoclonal antibody.

A J Caride1, A Enyedi, J T Penniston.   

Abstract

1. A monoclonal antibody (1G4) was raised against the red-cell Ca2+ pump, and it reacted with the pump, as verified by Western blot analysis and by the e.l.i.s.a. method. 2. At 1 mM-ATP and 10 microM-Ca2+, 1G4 inhibited the activity of the purified Ca2+ pump by 40%. 3. Ca2+ pump inhibition by the antibody was non-competitive with regard to Ca2+, calmodulin and the high-affinity portion of the ATP curve. Thus its mechanism was quite different from that of the antibody previously reported [Verbist, Wuytack, Raemaekers, VanLeuven, Cassiman & Casteels (1986) Biochem. J. 240, 633-640], which partially caused inhibition by competition at the ATP site. 4. Antibody 1G4 reduced the steady-state level of phosphorylated intermediate and increased by 50% the calmodulin-activated p-nitrophenyl phosphatase activity of the pump. 5. The experimental results are consistent with the hypothesis that 1G4 inhibits the Ca2+ pump by decreasing the rate of the transition from the E2 form to the E1 form, causing a higher concentration of E2. 6. Analysis by Western blot of the pattern of cross-reaction of 1G4 after tryptic digestion of the pump showed that this antibody reacts with bands of Mr 90,000, 85,000, 50,000 and 33,000. After chymotryptic digestion, the antibody reacts almost exclusively with a fragment of Mr 105,000 that is fully active but is not responsive to calmodulin. Altogether, the results indicate that 1G4 binds to an epitope involved in the functional properties of the enzyme but which is not related to the calmodulin-binding domain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2532506      PMCID: PMC1133550          DOI: 10.1042/bj2640087

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Two classes of site for ATP in the Ca2+-ATPase from human red cell membranes.

Authors:  D E Richards; A F Rega; P J Garrahan
Journal:  Biochim Biophys Acta       Date:  1978-08-04

2.  Purification of the (Ca2+-Mg2+)-ATPase from human erythrocyte membranes using a calmodulin affinity column.

Authors:  V Niggli; J T Penniston; E Carafoli
Journal:  J Biol Chem       Date:  1979-10-25       Impact factor: 5.157

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Topology of the erythrocyte Ca2+ pump. A monoclonal antibody against the almost inaccessible extracellular face.

Authors:  A J Caride; J P Gorski; J T Penniston
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  A rapid sensitive silver stain for polypeptides in polyacrylamide gels.

Authors:  C R Merril; M L Dunau; D Goldman
Journal:  Anal Biochem       Date:  1981-01-01       Impact factor: 3.365

7.  Characteristics and regulation of active calcium transport in inside-out red cell membrane vesicles.

Authors:  B Sarkadi; I Szász; G Gárdos
Journal:  Biochim Biophys Acta       Date:  1980-05-23

8.  Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle.

Authors:  L C Cantley; L Josephson; R Warner; M Yanagisawa; C Lechene; G Guidotti
Journal:  J Biol Chem       Date:  1977-11-10       Impact factor: 5.157

9.  Calcium ion-dependent p-nitrophenyl phosphate phosphatase activity and calcium ion-dependent adenosine triphosphatase activity from human erythrocyte membranes.

Authors:  A F Rega; D E Richards; P J Garrahan
Journal:  Biochem J       Date:  1973-09       Impact factor: 3.857

10.  Purified (Ca2+-Mg2+)-ATPase of the erythrocyte membrane. Reconstitution and effect of calmodulin and phospholipids.

Authors:  V Niggli; E S Adunyah; J T Penniston; E Carafoli
Journal:  J Biol Chem       Date:  1981-01-10       Impact factor: 5.157

View more
  2 in total

Review 1.  Plasma membrane calcium ATPases as novel candidates for therapeutic agent development.

Authors:  Emanuel E Strehler
Journal:  J Pharm Pharm Sci       Date:  2013       Impact factor: 2.327

2.  Metabolic regulation of calcium pumps in pancreatic cancer: role of phosphofructokinase-fructose-bisphosphatase-3 (PFKFB3).

Authors:  D A Richardson; P Sritangos; A D James; A Sultan; J I E Bruce
Journal:  Cancer Metab       Date:  2020-04-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.